EUVIMEDEUVIMED entdecken
Crossref

Treatment patterns and results of salvage treatment for regional recurrences after stereotactic ablative radiotherapy for primary non‐small cell lung cancer

Choong-Won Lee, Byoung Hyuck Kim, Hong-Gyun Wu, Hak Jae Kim

Asia-Pacific Journal of Clinical Oncology · 2024

DOI: 10.1111/ajco.13992 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Asia-Pacific Journal of Clinical Oncology, 2024. Verfasst von Choong-Won Lee und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Seoul National University Hospital, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Salvage Therapy, Lung Neoplasms, Radiosurgery, Carcinoma, Non-Small-Cell Lung. Die Arbeit nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Stereotactic ablative radiotherapy (SABR) for early‐stage lung cancer has shown promising results; however, regional recurrence (RR) development is not uncommon, and salvage treatment strategies have not been established. We aimed to investigate treatment patterns, prognostic factors, and survival outcomes. Materials and methods A retrospective analysis of 391 patients who underwent SABR for primary lung cancer from 2012 to 2019 was performed. Among these patients, 90 patients showed recurrence, including local recurrence ( n = 9), RR ( n = 33), distant metastasis (DM) ( n = 57), and RR with simultaneous DM ( n = 8). The median follow‐up duration was 17.3 months.

Results

The median age was 75 years, and most patients underwent primary SABR due to poor lung function (69.7%). Various salvage treatments were performed in cases of RR, including chemotherapy ( n = 15), radiotherapy ( n = 7), concurrent chemoradiotherapy ( n = 2), and best supportive care ( n = 9). The median overall survival (OS) and post‐recurrence OS (PR‐OS) were 22.9 and 11.2 months, respectively. In multivariate analysis, age ≤75 years (HR = 0.36, p = 0.040), isolated recurrence (HR = 0.34, p = 0.037), and radiotherapy without chemotherapy (HR = 0.25, p = 0.024) were significant prognostic factors for PR‐OS.

Conclusions

Despite various salvage treatments, PR‐OS was less than 1 year after RR in our frail patients group who underwent primary SABR. The toxicities of salvage chemotherapy could be quite severe; thus, careful patient selection is required. Further research is needed to validate our findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Salvage TherapyLung NeoplasmsRadiosurgeryCarcinoma, Non-Small-Cell LungNeoplasm Recurrence, LocalHumansAgedMaleFemaleRetrospective StudiesAged, 80 and overMiddle AgedPrognosisSurvival Rate

Stichwörter der Autor:innen

SABRnon‐small cell lung cancerregional recurrencesalvage treatment

Autor:innen und Institutionen

  • Department of Radiation Oncology, Seoul National University Hospital, Seoul, Republic of Korea.
  • Department of Radiation Oncology, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Republic of Korea.
  • Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Republic of Korea.

Zitieren

APA

Lee, C. W., Kim, B. H., Wu, H. G., & Kim, H. J. (2024). Treatment patterns and results of salvage treatment for regional recurrences after stereotactic ablative radiotherapy for primary non‐small cell lung cancer. Asia-Pacific Journal of Clinical Oncology. https://doi.org/10.1111/ajco.13992

Vancouver

Lee CW, Kim BH, Wu HG, Kim HJ. Treatment patterns and results of salvage treatment for regional recurrences after stereotactic ablative radiotherapy for primary non‐small cell lung cancer. Asia-Pacific Journal of Clinical Oncology. 2024. doi:10.1111/ajco.13992

BibTeX
@article{Lee2024,
  author = {Lee, Choong-Won and Kim, Byoung Hyuck and Wu, Hong-Gyun and Kim, Hak Jae},
  title = {Treatment patterns and results of salvage treatment for regional recurrences after stereotactic ablative radiotherapy for primary non‐small cell lung cancer},
  journal = {Asia-Pacific Journal of Clinical Oncology},
  year = {2024},
  doi = {10.1111/ajco.13992}
}
Kostenlos starten →